Trial Profile
Double Blind, Double Dummy, Multinational, Multicentre, Parallel-Group Design Clinical Trial of the Efficacy and Tolerability of CHF 1535 (Beclomethasone Dipropionate 100 µg + Formoterol 6 µg) pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler (Symbicort) in the 12-Week Treatment of Adult Patients With Moderate to Severe Persistent Asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ICAT-SY
- 28 Oct 2009 New trial record
- 01 Apr 2009 Results published in the European Respiratory Journal.